132
of treatment due to unrelated causes. At a median follow-up of
11 months, 1 patient developed regional recurrence and 1 patient
developed distant metastasis. 86% of patients in our study group
are disease free. There have been no flap related complications.
The mean time to decannulation in our study group was 2.6
months. All patients were able to resume a soft, pureed diet by a
mean time period of 3.1 months. 95% patients could be decannu-
lated however 1 patient had persistent aspiration necessitating
tracheostomy continuation.
Conclusion:
Our results indicate a reasonable functional outcome
with most patients being decannulated and able to start an oral
intake with oral volume and laryngeal elevation being significant
determinants.
http://dx.doi.org/10.1016/j.ijom.2017.02.458Spleen tyrosine kinase promotes the migration and invasion
of adenoid cystic carcinoma via long non-coding RNA H19
X. Qiao
∗
, C. Li, L. Li
Department of Head and Neck Oncology, West China Hospital
of Stomatology, Sichuan University, Chengdu, China
Background:
Adenoid cystic carcinoma (ACC) is common
malignant tumour of the salivary glands, which characteristic is
local invasion and distant metastasis. Recently, molecular targeted
therapy has been attracted more and more attentions, especially
the regulation of long non-coding RNA (lncRNA) for the invasion
and metastasis of malignant tumour.
Objectives:
The aim of this study was to investigate the correla-
tion between spleen tyrosine kinase (SYK) and the invasion and
metastasis of ACC, and further study to explore the molecular
mechanism that SYK promotes the secretion of matrixmetallopro-
teinase (MMP)-2/9, vascular endothelial growth factor (VEGF) by
regulating lncRNA H19.
Methods:
We analysed the clinical samples via reverse
transcriptase-polymerase chain reaction (RT-PCR) to explore the
relationship between the expression of lncRNA H19 and the prog-
nosis of patients.
In vitro
, we inhibited SYK and lncRNA H19
respectively via SiRNA, and we also investigate the function and
mechanism by using Transwell and Western blot. And finally
we confirmed our results via
in vivo
study through nude mouse
tumourigenicity assay.
Results and Conclusion:
RT-PCR revealed that there are sig-
nificant positive correlations between H19 expression level and
prognosis of patients with ACC. Suppression SYK can inhibit H19
expression. When SYK and H19 were inhibited respectively, the
migration and invasion ability of ACC were both decreased, and
the expression of MMP-2/9, VEGF were downregulated.
In vivo
,
when we inhibited the H19, the tumour volume and weight were
both decreased. Thus, we can conclude that SYK can upregu-
late the expression of MMP-2/9 and VEGF via lncRNA H19,
promoting the progression of ACC.
http://dx.doi.org/10.1016/j.ijom.2017.02.459An update on the use of Secondi Mapz to classify oncological
defects of the midface
S. Richardson
∗
, C. Hughes, L. Noyon, W. Kerkri,
M. Abu Serriah
Royal Melbourne Hospital, Melbourne, Australia
A novel classification system, Secondi Mapz, was recently pro-
posed to allow succinct and precise recording of oncological
defects of the midface. Despite there being many midfacial defect
classification systems in existence, there is no universally accepted
standard. The lack of consensus stems from the deficiencies in the
published classification systems — being class based, ambigu-
ous, and based on retrospective data sets. In addition, different
systems use imprecise terms such as ‘extended maxillectomy’ to
include a wide variety of defects, which make it difficult to com-
pare outcome. Secondi Mapz was designed to capture pertinent
anatomical information of the midface and adjacent structures (i.e.
skin, ethmoid, cranium, orbit, nose, dentition, infratemporal fossa,
maxillary sinus, alveolus, palate, zygomatic complex, dura, peri-
orbita, nasal mucoperiosteum, and maxillary sinus lining) in all
three dimensions (superior-inferior, anterior-posterior, and lateral-
medial). Secondi Mapz is designed to be used primarily in research
to facilitate written communication, allow accurate data record-
ing and comparison, and ultimately, lead to better patient care.
It can also be used within our multidisciplinary team to facili-
tate treatment planning. We present data on the validation of the
Secondi Mapz classification, as well as introducing a new web
based portal to allow user-friendly access to a central database:
www.secondimapz.com http://dx.doi.org/10.1016/j.ijom.2017.02.460Case report: malignant melanoma of the left lateral rectus
muscle and a review of the literature surrounding metastatic
disease within extraocular muscles
S.A. Rizvi
∗
, C. Hendy, K. Lewis
William Harvey Hospital, Ashford, United Kingdom
Melanoma, also known as malignant melanoma is a type of can-
cer, arising from pigment producing melanocytes. Melanoma is
thought to typically originate in the skin, although it can metasta-
sise to other parts of the body. However, the incidence of metastasis
occurring within the extraocular muscles of the orbit is extremely
low. Therefore, the case we present is of an unusual nature. The
case is of a medically fit and well, 46-year-old gentleman who
initially presented with diplopia, proptosis and unable to carry out
lateral movements of his left eye.
The patient underwent several scans including magnetic reso-
nance imaging of orbits and a computed tomography of the face,
and was diagnosed as suffering frommetastatic melanoma associ-
ated with the lateral rectus of the left eye with no known primary
tumour. The patient underwent a resection of his left eye carried
out but months later, the melanoma recurred and an exenteration
of the patients’ left orbit was carried out. The final histology report
of the melanoma from the left orbit showed epitheloid, spindle and
clear cells with focal pigmentation and positivity for S100 protein
and Melan-A.
A review of the literature surrounding metastasis within
extraocular muscles shows that metastases from other cancers




